Rybak, Michael J.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association

Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation

Infective Endocarditis Diagnosis and ManagementStreptococcal Infections and Treatments

Cited by 3,232

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy

Antibiotics Pharmacokinetics and EfficacyAntimicrobial Resistance in Staphylococcus

Cited by 1,795

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusInfection Control in Healthcare

Cited by 604

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 463

Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model

LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management

Cited by 284

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Werth, B. J., Sakoulas, G., Rose, W. E., Pogliano, J., Tewhey, R., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 134

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐Resistant Staphylococcus aureus Isolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

Bae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases

Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management

Cited by 122

Pharmacodynamics: Relation to Antimicrobial Resistance

Rybak, M. J. (2006) · The American Journal of Medicine

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 120

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

Casapao, A. M., Davis, S. L., Barr, V. O., Klinker, K. P., Goff, D. A., Barber, K. E., Kaye, K. S., Mynatt, R. P., Molloy, L. M., Pogue, J. M., et al. (2014) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 108

Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study

Chirouze, C., Alla, F., Fowler, V. G., Sexton, D. J., Corey, G. R., Chu, V. H., Wang, A., Erpelding, M.-L., Durante-Mangoni, E., Fernández-Hidalgo, N., et al. (2015) · Clinical Infectious Diseases

Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments

Cited by 104

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Kullar, R., Casapao, A. M., Davis, S. L., Levine, D. P., Zhao, J. J., Crank, C. W., Segreti, J., Sakoulas, G., Cosgrove, S. E., & Rybak, M. J. (2013) · Journal of Antimicrobial Chemotherapy

Infective Endocarditis Diagnosis and ManagementAntimicrobial Resistance in Staphylococcus

Cited by 99

Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Rose, W. E., Leonard, S. N., Sakoulas, G., Kaatz, G. W., Zervos, M. J., Sheth, A., Carpenter, C. F., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management

Cited by 81

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Werth, B. J., Vidaillac, C., Murray, K. P., Newton, K. L., Sakoulas, G., Nonejuie, P., Pogliano, J., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusAntibiotic Resistance in Bacteria

Cited by 69

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations

Steed, M. E., Vidaillac, C., & Rybak, M. J. (2010) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management

Cited by 57

Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model

Rose, W. E., Leonard, S. N., Rossi, K. L., Kaatz, G. W., & Rybak, M. J. (2009) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 37